These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7856734)

  • 1. Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice.
    Boivin GP; O'Toole BA; Orsmby IE; Diebold RJ; Eis MJ; Doetschman T; Kier AB
    Am J Pathol; 1995 Jan; 146(1):276-88. PubMed ID: 7856734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders.
    Kulkarni AB; Ward JM; Yaswen L; Mackall CL; Bauer SR; Huh CG; Gress RE; Karlsson S
    Am J Pathol; 1995 Jan; 146(1):264-75. PubMed ID: 7856732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.
    Shull MM; Ormsby I; Kier AB; Pawlowski S; Diebold RJ; Yin M; Allen R; Sidman C; Proetzel G; Calvin D
    Nature; 1992 Oct; 359(6397):693-9. PubMed ID: 1436033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Female mice are more susceptible to developing inflammatory disorders due to impaired transforming growth factor beta signaling in salivary glands.
    Nandula SR; Amarnath S; Molinolo A; Bandyopadhyay BC; Hall B; Goldsmith CM; Zheng C; Larsson J; Sreenath T; Chen W; Ambudkar IS; Karlsson S; Baum BJ; Kulkarni AB
    Arthritis Rheum; 2007 Jun; 56(6):1798-805. PubMed ID: 17530708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.
    Kulkarni AB; Huh CG; Becker D; Geiser A; Lyght M; Flanders KC; Roberts AB; Sporn MB; Ward JM; Karlsson S
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):770-4. PubMed ID: 8421714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wound healing in the transforming growth factor-beta-deficient mouse.
    Brown RL; Ormsby I; Doetschman TC; Greenhalgh DG
    Wound Repair Regen; 1995; 3(1):25-36. PubMed ID: 17168860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta 2-microglobulin-deficient background ameliorates lethal phenotype of the TGF-beta 1 null mouse.
    Kobayashi S; Yoshida K; Ward JM; Letterio JJ; Longenecker G; Yaswen L; Mittleman B; Mozes E; Roberts AB; Karlsson S; Kulkarni AB
    J Immunol; 1999 Oct; 163(7):4013-9. PubMed ID: 10491004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germ-free and barrier-raised TGF beta 1-deficient mice have similar inflammatory lesions.
    Boivin GP; Ormsby I; Jones-Carson J; O'Toole BA; Doetschman T
    Transgenic Res; 1997 May; 6(3):197-202. PubMed ID: 9167267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated.
    Diebold RJ; Eis MJ; Yin M; Ormsby I; Boivin GP; Darrow BJ; Saffitz JE; Doetschman T
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12215-9. PubMed ID: 8618872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The liver in transforming growth factor-Beta-1 (TGF-beta 1) null mutant mice.
    Williams AO; Knapton AD; Geiser A; Letterio JJ; Roberts AB
    Ultrastruct Pathol; 1996; 20(5):477-90. PubMed ID: 8883333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric lesions in transforming growth factor beta-1 heterozygous mice.
    Boivin GP; Molina JR; Ormsby I; Stemmermann G; Doetschman T
    Lab Invest; 1996 Feb; 74(2):513-8. PubMed ID: 8780168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids, TGF-beta, and embryonic mouse salivary gland morphogenesis.
    Jaskoll T; Choy HA; Melnick M
    J Craniofac Genet Dev Biol; 1994; 14(4):217-30. PubMed ID: 7883868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet.
    Luo XY; Takahara T; Kawai K; Fujino M; Sugiyama T; Tsuneyama K; Tsukada K; Nakae S; Zhong L; Li XK
    Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G891-9. PubMed ID: 24136786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed wound healing in immunodeficient TGF-beta 1 knockout mice.
    Crowe MJ; Doetschman T; Greenhalgh DG
    J Invest Dermatol; 2000 Jul; 115(1):3-11. PubMed ID: 10886500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene.
    Böttinger EP; Jakubczak JL; Haines DC; Bagnall K; Wakefield LM
    Cancer Res; 1997 Dec; 57(24):5564-70. PubMed ID: 9407968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced programmed cell death in the retina and defects in lens and cornea of Tgfbeta2(-/-) Tgfbeta3(-/-) double-deficient mice.
    Dünker N; Krieglstein K
    Cell Tissue Res; 2003 Jul; 313(1):1-10. PubMed ID: 12838410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-alpha deficiency reduces pulmonary fibrosis in transgenic mice.
    Madtes DK; Elston AL; Hackman RC; Dunn AR; Clark JG
    Am J Respir Cell Mol Biol; 1999 May; 20(5):924-34. PubMed ID: 10226062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirt7 Contributes to Myocardial Tissue Repair by Maintaining Transforming Growth Factor-β Signaling Pathway.
    Araki S; Izumiya Y; Rokutanda T; Ianni A; Hanatani S; Kimura Y; Onoue Y; Senokuchi T; Yoshizawa T; Yasuda O; Koitabashi N; Kurabayashi M; Braun T; Bober E; Yamagata K; Ogawa H
    Circulation; 2015 Sep; 132(12):1081-93. PubMed ID: 26202810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and TGF beta 1: lessons from the TGF beta 1 null mouse.
    Kulkarni AB; Karlsson S
    Res Immunol; 1997 Sep; 148(7):453-6. PubMed ID: 9498004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.